An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
NCT02320032
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
140
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Aripiprazole Lauroxil
Sponsor
Alkermes, Inc.